MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Rockwell Medical Operating Cycle 2011-2026 | RMTI
Annual Operating Cycle Rockwell Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65.9 | 56.8 | 52.4 | 48.5 | 47.8 | 65 | 92.5 | 139 | 95.2 | 61.5 | 54.3 | 54.9 | 52.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 139 | 47.8 | 68.2 |
Quarterly Operating Cycle Rockwell Medical
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.2 | 79.9 | - | 56.1 | 64.4 | 72 | - | 52.2 | 59.4 | 59 | - | 63.7 | 66 | 62.8 | - | 56.9 | 62.1 | 56.1 | - | 30.2 | 30.1 | 29.8 | - | 46.5 | 49.4 | 56.9 | - | 63.3 | 62.2 | 74.7 | - | 91.1 | 103 | 39.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 29.8 | 60.1 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
230 | $ 1.14 | -1.73 % | $ 123 M |  Canada |
 |
Cronos Group
CRON
|
425 | $ 2.63 | - | $ 1.38 B | Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
152 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 4.19 | -1.64 % | $ 86.3 M | Canada |
 |
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
237 | $ 12.39 | 1.98 % | $ 634 M | USA |
 |
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
416 | $ 21.56 | 0.07 % | $ 2.05 B |  France |
 |
Evolus
EOLS
|
104 | $ 6.67 | -0.07 % | $ 414 M | USA |
 |
Harrow Health
HROW
|
102 | $ 49.34 | -1.36 % | $ 1.61 B | USA |
 |
China Pharma Holdings
CPHI
|
198 | $ 1.22 | -8.65 % | $ 21.3 M |  China |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.69 | -0.88 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
78.9 | $ 6.96 | -0.43 % | $ 2.54 B | Canada |
 |
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
614 | $ 3.96 | -0.13 % | $ 55.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
159 | $ 5.14 | -0.77 % | $ 677 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 26.04 | -0.12 % | $ 1.2 B | USA |
 |
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
194 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
201 | $ 13.91 | -0.22 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
141 | $ 0.44 | -2.36 % | $ 6.97 M | USA |
 |
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
459 | $ 9.08 | -1.3 % | $ 645 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
182 | $ 3.54 | -2.13 % | $ 4.39 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 0.63 | 3.22 % | $ 30.1 M | USA |
 |
Tilray
TLRY
|
222 | $ 8.97 | -0.54 % | $ 5.54 B | Canada |
 |
Veru
VERU
|
271 | $ 2.13 | -1.84 % | $ 287 M | USA |
 |
TherapeuticsMD
TXMD
|
3.34 K | $ 1.63 | -0.61 % | $ 17 M | USA |
 |
Viatris
VTRS
|
219 | $ 12.52 | -0.2 % | $ 15.2 B | USA |
 |
cbdMD
YCBD
|
176 | $ 1.37 | 0.37 % | $ 5.91 M | USA |